Incidence, clinical characteristics and outcome of congestive heart failure as the initial presentation in patients with primary hyperthyroidism

Heart

Volumn 93, Issue 4, 2007, Pages 483-487

  Siu, Chung Wah ^a   Yeung, Chun Yip ^a   Lau, Chu Pak ^a   Kung, Annie W C ^a   Tse, Hung Fat ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBIMAZOLE; DIURETIC AGENT; RADIOACTIVE IODINE; THYROXINE;

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; EUTHYROIDISM; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; THYROXINE BLOOD LEVEL;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTHYROIDISM; MALE; MIDDLE AGED; PROGNOSIS; SEX FACTORS;

EID: 34247331316     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2006.100628     Document Type: Article

References (24)

1. Polikar R, Burger AG, Scherrer U, et al. The thyroid and the heart. Circulation 1993;87:1435-41.
2. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med 2001;344:501-9.
3. Klein I. Thyroid hormone and the cardiovascular system. Am J Med 1990;88:631-7.
4. Kahaly GJ, Kampmann C, Mohr-Kahaly S. Cardiovascular hemodynamics and exercise tolerance in thyroid disease. Thyroid 2002;12:473-81.
5. Feldman T, Borow KM, Sarne DH, et al. Myocardial mechanics in hyperthyroidism: importance of left ventricular loading conditions, heart rate and contractile state. J Am Coll Cardiol 1986;7:967-74.
6. Forfar JC, Muir AL, Sawers SA, et al. Abnormal left ventricular function in hyperthyroidism. Evidence for a possible reversible cardiomyopathy. N Engl J Med 1982;307:1165-70.
7. Polikar R, Burger AG, Scherrer U, et al. The thyroid and the heart. Circulation 1993;87:1435-41.
8. Shirani J, Barron MM, Pierre-Louis ML, et al. Congestive heart failure, dilated cardiac ventricles, and sudden death in hyperthyroidism. Am J Cardiol 1993;72:365-8.
9. Umpierrez GE, Challapalli S, Patterson C. Congestive heart failure due to reversible cardiomyopathy in patients with hyperthyroidism. Am J Med Sci 1995;310:99-102.
10. Watanabe E, Ohsawa H, Noike H, et al. Dilated cardiomyopathy associated with hyperthyroidism. Intern Med 1995;34:762-7.
11. Boccalandro C, Boccalandro F, Orlander P, et al. Severe reversible dilated cardiomyopathy and hyperthyroidism: case report and review of literature. Endocr Pract 2003;9:140-6.
12. Kasper EK, Agema WR, Hutchins GM, et al. The causes of dilated cardiomyopathy: a clinicopathologic review of 673 consecutive patients. J Am Coll Cardiol 1994;23:586-90.
13. Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 1998;98:2282-9.
14. Redfield MM, Jacobsen SJ, Burnett JC Jr, et al. Burden of systolic and diastolic ventricular dysfunction in the communily: appreciating the scope of the heart failure epidemic. JAMA 2003;289:194-202.
15. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
16. Klein I, Ojamaa K. Thyrotoxicosis and the heart. Endocrinol Metab Clin North Am 1998;27:51-62.
17. DeGroot WJ, Leonard JJ. Hyperthyroidism as a high cardiac output state. Am Heart J 1970;79:265-75.
18. Koshiyama H, Sellitti DF, Akamizu T, et al. Cardiomyopathy associated with Graves' disease. Clin Endocrinol (Oxf), 1996;45:111-16.
19. Sachs RN, Vignot M, Modigliani E, et al. Absence of ultra-structural histological lesions of the myocardium in cardiac insufficiency of hyperthyroidism. Ann Med Interne 1986;137:375-8.
20. Ebisawa K, Ikeda U, Murata M, et al. Irreversible cardiomyopathy due to thyrotoxicosis. Cardiology 1994;84:274-7.
21. Fatourechi V, Edwards WD. Graves' disease and low-output cardiac dysfunction: implications for autoimmune disease in endomyocardial biopsy tissue from eleven patients. Thyroid 2000;10:601-5.
22. Marti V, Ballester M, Rigla M, et al. Myocardial damage does not occur in untreated hyperthyroidism unless associated with congestive heart failure. Am Heart J 1997;134:1133-7.
23. Matsuoka H, Hamada M, Honda T, et al. Precise assessment of myocardial damage associated with secondary cardiomyopathies by use of Gd-DTPA-enhanced magnetic resonance imaging. Angiology 1993;44:945-50.
24. Gao XM, Agrotis A, Autelitano DJ, et al. Sex hormones and cardiomyopathic phenotype induced by cardiac beta 2-adrenergic receptor overexpression. Endocrinology 2003;144:4097-105.